Evaluation of the effect of class C ODN-2395 as TLR9A in controlling LM progression and its impact on the liver MDSC population.
You are now leaving the TriSalus Life Sciences corporate website.
Third Party Sites
TriSalus assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of TriSalus or this website.